Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies

Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and morbidity in the perinatal period. This condition results from a period of ischemia and hypoxia to the brain of neonates, leading to several disorders that profoundly affect the daily life of patients and their fam...

Full description

Bibliographic Details
Main Authors: Inês Serrenho, Miguel Rosado, Alexandra Dinis, Carla M. Cardoso, Mário Grãos, Bruno Manadas, Graça Baltazar
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/6/3142
_version_ 1797540767164530688
author Inês Serrenho
Miguel Rosado
Alexandra Dinis
Carla M. Cardoso
Mário Grãos
Bruno Manadas
Graça Baltazar
author_facet Inês Serrenho
Miguel Rosado
Alexandra Dinis
Carla M. Cardoso
Mário Grãos
Bruno Manadas
Graça Baltazar
author_sort Inês Serrenho
collection DOAJ
description Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and morbidity in the perinatal period. This condition results from a period of ischemia and hypoxia to the brain of neonates, leading to several disorders that profoundly affect the daily life of patients and their families. Currently, therapeutic hypothermia (TH) is the standard of care in developing countries; however, TH is not always effective, especially in severe cases of HIE. Addressing this concern, several preclinical studies assessed the potential of stem cell therapy (SCT) for HIE. With this systematic review, we gathered information included in 58 preclinical studies from the last decade, focusing on the ones using stem cells isolated from the umbilical cord blood, umbilical cord tissue, placenta, and bone marrow. Outstandingly, about 80% of these studies reported a significant improvement of cognitive and/or sensorimotor function, as well as decreased brain damage. These results show the potential of SCT for HIE and the possibility of this therapy, in combination with TH, becoming the next therapeutic approach for HIE. Nonetheless, few preclinical studies assessed the combination of TH and SCT for HIE, and the existent studies show some contradictory results, revealing the need to further explore this line of research.
first_indexed 2024-03-10T13:06:16Z
format Article
id doaj.art-e799d13b6bc942868314b3475c358a4d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T13:06:16Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e799d13b6bc942868314b3475c358a4d2023-11-21T11:10:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01226314210.3390/ijms22063142Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical StudiesInês Serrenho0Miguel Rosado1Alexandra Dinis2Carla M. Cardoso3Mário Grãos4Bruno Manadas5Graça Baltazar6Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilhã, PortugalCNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, PortugalPediatric Intensive Care Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, PortugalCrioestaminal, 3060-197 Cantanhede, PortugalCNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, PortugalCNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, PortugalCentro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilhã, PortugalNeonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and morbidity in the perinatal period. This condition results from a period of ischemia and hypoxia to the brain of neonates, leading to several disorders that profoundly affect the daily life of patients and their families. Currently, therapeutic hypothermia (TH) is the standard of care in developing countries; however, TH is not always effective, especially in severe cases of HIE. Addressing this concern, several preclinical studies assessed the potential of stem cell therapy (SCT) for HIE. With this systematic review, we gathered information included in 58 preclinical studies from the last decade, focusing on the ones using stem cells isolated from the umbilical cord blood, umbilical cord tissue, placenta, and bone marrow. Outstandingly, about 80% of these studies reported a significant improvement of cognitive and/or sensorimotor function, as well as decreased brain damage. These results show the potential of SCT for HIE and the possibility of this therapy, in combination with TH, becoming the next therapeutic approach for HIE. Nonetheless, few preclinical studies assessed the combination of TH and SCT for HIE, and the existent studies show some contradictory results, revealing the need to further explore this line of research.https://www.mdpi.com/1422-0067/22/6/3142hypoxic-ischemic encephalopathystem cell therapyumbilical cord blood cellsumbilical cord tissuemesenchymal stem/stromal cellstherapeutic hypothermia
spellingShingle Inês Serrenho
Miguel Rosado
Alexandra Dinis
Carla M. Cardoso
Mário Grãos
Bruno Manadas
Graça Baltazar
Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
International Journal of Molecular Sciences
hypoxic-ischemic encephalopathy
stem cell therapy
umbilical cord blood cells
umbilical cord tissue
mesenchymal stem/stromal cells
therapeutic hypothermia
title Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
title_full Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
title_fullStr Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
title_full_unstemmed Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
title_short Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
title_sort stem cell therapy for neonatal hypoxic ischemic encephalopathy a systematic review of preclinical studies
topic hypoxic-ischemic encephalopathy
stem cell therapy
umbilical cord blood cells
umbilical cord tissue
mesenchymal stem/stromal cells
therapeutic hypothermia
url https://www.mdpi.com/1422-0067/22/6/3142
work_keys_str_mv AT inesserrenho stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT miguelrosado stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT alexandradinis stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT carlamcardoso stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT mariograos stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT brunomanadas stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies
AT gracabaltazar stemcelltherapyforneonatalhypoxicischemicencephalopathyasystematicreviewofpreclinicalstudies